| Pharmaceutical active ingredients: |
| HydrochlorothiazideLosartan Potassium |
| Available forms, composition and doses of Neo-Lotan Plus: |
| N / A |
| Neo-Lotan Plus medical category: |
| Human:Angiotensin II receptor antagonistsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09DA01 - Losartan and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Neopharmed |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lozap Plus | Hydrochlorothiazide; Losartan Potassium | Zentiva |
| LSP Plus | Hydrochlorothiazide; Losartan Potassium | Plus India |
| LSR-H | Hydrochlorothiazide; Losartan Potassium | Medihealth |
| LTP-H | Hydrochlorothiazide; Losartan Potassium | Sigman Wellness |
| Nefrotal H | Hydrochlorothiazide; Losartan Potassium | Rowe-Fleming Laboratorios |
| Neopress | Hydrochlorothiazide; Losartan Potassium | Neo Quimica Comercio e Industria Laboratorio |
| Neosartan Plus | Hydrochlorothiazide; Losartan Potassium | GX International; Metro Drug Distribution |
| Nipartan-H | Hydrochlorothiazide; Losartan Potassium | Micro Labs; Brown & Burk Pharmaceuticals |
| Niten D | Hydrochlorothiazide; Losartan Potassium | IVAX |
| Nusar-H | Hydrochlorothiazide; Losartan Potassium | Emcure Pharmaceuticals |